Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Høiby

Showing results (1-10 of 344) with videos related to

Pageof 35
Sort By:
The Netherlands Journal of Medicine|June 1, 1995
Isolation and treatment of cystic fibrosis patients with lung infections caused by Pseudomonas (Burkholderia) cepacia and multiresistant Pseudomonas aeruginosaN Høiby
Microbial Drug Resistance (Larchmont, N.Y.)|July 1, 1995
Epidemiologic aspects on antibiotic resistanceN Høiby
European Journal of Clinical Microbiology|April 1, 1986
Clinical uses of nalidixic acid analogues: the fluoroquinolonesN Høiby
Ugeskrift for Laeger|December 18, 1989
[Erythromycin--current small-spectrum antibiotics]N Høiby
Ugeskrift for Laeger|January 5, 2002
[Anthrax transmission from patient to patient?]N Høiby
The European Respiratory Journal|April 20, 2001
Inflammation and infection in cystic fibrosis--hen or egg?N Høiby
Ugeskrift for Laeger|April 25, 1994
[Use of antibiotics in the USA and other foreign places--in spite of the lifted index finger of the Statue of Liberty]N Høiby
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1989
Ciprofloxacin in urinary tract infectionsN Høiby
Paediatric Drugs|December 29, 2000
Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosisN Høiby
Current Opinion in Pediatrics|June 1, 1993
Cystic fibrosis and endobronchial pseudomonas infectionN Høiby
Pageof 35

Showing results (1-10 of 344) with videos related to

Sort By:
Pageof 35
The Netherlands Journal of Medicine|June 1, 1995
Isolation and treatment of cystic fibrosis patients with lung infections caused by Pseudomonas (Burkholderia) cepacia and multiresistant Pseudomonas aeruginosaN Høiby
Microbial Drug Resistance (Larchmont, N.Y.)|July 1, 1995
Epidemiologic aspects on antibiotic resistanceN Høiby
European Journal of Clinical Microbiology|April 1, 1986
Clinical uses of nalidixic acid analogues: the fluoroquinolonesN Høiby
Ugeskrift for Laeger|December 18, 1989
[Erythromycin--current small-spectrum antibiotics]N Høiby
Ugeskrift for Laeger|January 5, 2002
[Anthrax transmission from patient to patient?]N Høiby
The European Respiratory Journal|April 20, 2001
Inflammation and infection in cystic fibrosis--hen or egg?N Høiby
Ugeskrift for Laeger|April 25, 1994
[Use of antibiotics in the USA and other foreign places--in spite of the lifted index finger of the Statue of Liberty]N Høiby
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1989
Ciprofloxacin in urinary tract infectionsN Høiby
Paediatric Drugs|December 29, 2000
Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosisN Høiby
Current Opinion in Pediatrics|June 1, 1993
Cystic fibrosis and endobronchial pseudomonas infectionN Høiby
Pageof 35